|
|
循环肿瘤细胞检测方法在食管癌中的应用及展望
|
Abstract:
食管癌作为世界上最常见的恶性肿瘤之一，具有较高的发病率及死亡率。及时发现和诊断食管癌对患者的治疗和预后至关重要。现有诊断与长期监测食管癌的方法具有一定的局限性，如影像学检测受限于肿瘤大小；鳞状细胞癌抗原(squamous cell carcinoma antigen, SCCA)、癌胚抗原(carcinoembryonic antigen, CEA)等血清肿瘤标志物的特异性和准确性较低；组织病理学作为肿瘤诊断的“金标准”，但是侵入性检查，且由于肿瘤的异质性，病理活检有其局限性。循环肿瘤细胞(circulating tumor cells, CTCs)是指从原发肿瘤病灶中脱落并随血液循环到达身体各处的肿瘤细胞，针对CTCs的检测事新兴的液体活检方法之一，被广泛应用于研究各种肿瘤。本文综述了循环肿瘤细胞的分离及富集方法，并综述了CTCs与食管癌放化疗之间的研究，并对其未来进行展望。
As one of the most common malignant tumors in the world, esophageal cancer has high morbidity and mortality. Timely detection and diagnosis of esophageal cancer is crucial to the treatment and prognosis of patients. The existing methods for diagnosis and long-term monitoring of esophageal cancer have certain limitations, for example, imaging detection is limited by tumor size. The speci-ficity and accuracy of serum tumor markers such as squamous cell carcinoma (SCC) antigen and carcinoembryonic antigen (CEA) are low. Histopathology is the “gold standard” for tumor diagnosis, but it’s an invasive medical test, pathological biopsy has its limitations due to the heterogeneity of tumor. Circulating tumor cells (CTCs) are tumor cells that fall out of the primary tumor focus and reach all parts of the body with blood circulation. The detection of CTC is one of the emerging liquid biopsy methods, and is widely used to study various tumors. In this paper, the separation and en-richment methods of circulating tumor cells are reviewed, and the research between CTC and radi-otherapy and chemotherapy of esophageal cancer is reviewed, and its future is prospected.
| [1] | Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249.
https://doi.org/10.3322/caac.21660 |
| [2] | Chen, Y., Yang, Z., Wang, Y., et al. (2019) Karyotyping of Circulating Tumor Cells for Predicting Chemotherapeutic Sensitivity and Efficacy in Patients with Esophageal Cancer. BMC Cancer, 19, 651.
https://doi.org/10.1186/s12885-019-5850-7 |
| [3] | Gao, Q.Y. and Fang, J.Y. (2015) Early Esophageal Cancer Screening in China. Best Practice & Research Clinical Gastroenterology, 29, 885-893. https://doi.org/10.1016/j.bpg.2015.09.018 |
| [4] | Krebs, M.G., Metcalf, R.L., Carter, L., et al. (2014) Molecular Analysis of Circulating Tumour Cells—Biology and Biomarkers. Nature Reviews Clinical Oncology, 11, 129-144. https://doi.org/10.1038/nrclinonc.2013.253 |
| [5] | Lianidou, E.S. (2014) Circulating Tumor Cell Isolation: A Mara-thon Race Worth Running. Clinical Chemistry, 60, 287-289. https://doi.org/10.1373/clinchem.2013.216010 |
| [6] | Alix-Panabières, C. and Pantel, K. (2013) Circulating Tumor Cells: Liquid Biopsy of Cancer. Clinical Chemistry, 59, 110-118. https://doi.org/10.1373/clinchem.2012.194258 |
| [7] | Plaks, V., Koopman, C.D. and Werb, Z. (2013) Circulating Tumor Cells. Science, 341, 1186-1188.
https://doi.org/10.1126/science.1235226 |
| [8] | Cristofanilli, M., Stopeck, A. and Reuben, J.M. (2004) Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer. The New England Journal of Medicine, 351, 781-791.
https://doi.org/10.1056/NEJMoa040766 |
| [9] | Hou, J.M., Krebs, M.G., Lancashire, L., et al. (2012) Clinical Signif-icance and Molecular Characteristics of Circulating Tumor Cells and Circulating Tumor Microemboli in Patients with Small-Cell Lung Cancer. Journal of Clinical Oncology, 30, 525-532. https://doi.org/10.1200/JCO.2010.33.3716 |
| [10] | Peeters, D.J.E., Brouwer, A., Van Den Eynden, G.G., et al. (2015) Circulating Tumour Cells and Lung Microvascular Tumour Cell Retention in Patients with Metastatic Breast and Cervical Cancer. Cancer Letters, 356, 872-879.
https://doi.org/10.1016/j.canlet.2014.10.039 |
| [11] | Umer, M., Vaidyanathan, R., Nguyen, N.T., et al. (2018) Circu-lating Tumor Microemboli: Progress in Molecular Understanding and Enrichment Technologies. Biotechnology Advanc-es, 36, 1367-1389.
https://doi.org/10.1016/j.biotechadv.2018.05.002 |
| [12] | Hanahan, D. and Weinberg, R.A. (2011) Hallmarks of Cancer: The Next Generation. Cell, 144, 646-674.
https://doi.org/10.1016/j.cell.2011.02.013 |
| [13] | Allard, W.J., Matera, J. and Miller, M.C. (2004) Tumor Cells Cir-culate in the Peripheral Blood of All Major Carcinomas but Not in Healthy Subjects or Patients with Nonmalignant Dis-eases. Clinical Cancer Research, 10, 6897-6904.
https://doi.org/10.1158/1078-0432.CCR-04-0378 |
| [14] | Riethdorf, S., O’Flaherty, L., Hille, C., et al. (2018) Clinical Applications of the Cell Search Platform in Cancer Patients. Advanced Drug Delivery Reviews, 125, 102-121. https://doi.org/10.1016/j.addr.2018.01.011 |
| [15] | Mostert, B., Kraan, J., Bolt-De Vries, J., et al. (2011) Detection of Circulating Tumor Cells in Breast Cancer May Improve through Enrichment with Anti-CD146. Breast Cancer Research and Treatment, 127, 33-41.
https://doi.org/10.1007/s10549-010-0879-y |
| [16] | Smirnov, D.A., Zweitzig, D.R., Foulk, B.W., et al. (2005) Global Gene Expression Profiling of Circulating Tumor Cells. Cancer Research, 65, 4993-4997. https://doi.org/10.1158/0008-5472.CAN-04-4330 |
| [17] | Hong, Y., Fang, F. and Zhang, Q. (2016) Circulating Tu-mor Cell Clusters: What We Know and What We Expect (Review). International Journal of Oncology, 49, 2206-2216. https://doi.org/10.3892/ijo.2016.3747 |
| [18] | Sarioglu, A.F., Aceto, N., Kojic, N., et al. (2015) A Microfluidic Device for Label-Free, Physical Capture of Circulating Tumor Cell Clusters. Nature Methods, 12, 685-691. https://doi.org/10.1038/nmeth.3404 |
| [19] | Alix-Panabières, C., Schwarzenbach, H. and Pantel, K. (2012) Circulating Tumor Cells and Circulating Tumor DNA. Annual Review of Medicine, 63, 199-215. https://doi.org/10.1146/annurev-med-062310-094219 |
| [20] | Cann, G.M., Gulzar, Z.G., Cooper, S., et al. (2012) mRNA-Seq of Single Prostate Cancer Circulating Tumor Cells Reveals Recapitulation of Gene Expression and Pathways Found in Prostate Cancer. PLOS ONE, 7, e49144.
https://doi.org/10.1371/journal.pone.0049144 |
| [21] | Drucker, A., Teh, E.M., Kostyleva, R., et al. (2020) Compara-tive Performance of Different Methods for Circulating Tumor Cell Enrichment in Metastatic Breast Cancer Patients. PLOS ONE, 15, e0237308.
https://doi.org/10.1371/journal.pone.0237308 |
| [22] | Zhang, X., Lu, X., Gao, W., et al. (2021) A Label-Free Micro-fluidic Chip for the Highly Selective Isolation of Single and Cluster CTCs from Breast Cancer Patients. Translational Oncology, 14, Article ID: 100959.
https://doi.org/10.1016/j.tranon.2020.100959 |
| [23] | Yin, J., Mou, L., Yang, M., et al. (2019) Highly Efficient Cap-ture of Circulating Tumor Cells with Low Background Signals by Using Pyramidal Microcavity Array. Analytica Chim-ica Acta, 1060, 133-141.
https://doi.org/10.1016/j.aca.2019.01.054 |
| [24] | Armbrecht, L., Rutschmann, O., Szczerba, B.M., et al. (2020) Quantification of Protein Secretion from Circulating Tumor Cells in Microfluidic Chambers. Advanced Science, 7, Article ID: 1903237.
https://doi.org/10.1002/advs.201903237 |
| [25] | Chen, H., Cao, B., Sun, B., et al. (2017) Highly-Sensitive Capture of Circulating Tumor Cells Using Micro-Ellipse Filters. Scientific Reports, 7, 610. https://doi.org/10.1038/s41598-017-00232-6 |
| [26] | Park, E.S., Jin, C., Guo, Q., et al. (2016) Continuous Flow De-formability-Based Separation of Circulating Tumor Cells Using Microfluidic Ratchets. Small, 12, 1909-1919. https://doi.org/10.1002/smll.201503639 |
| [27] | Hosokawa, M., Hayata, T., Fukuda, Y., et al. (2010) Size-Selective Microcavity Array for Rapid and Efficient Detection of Circulating Tumor Cells. Analytical Chemistry, 82, 6629-6635. https://doi.org/10.1021/ac101222x |
| [28] | Hvichia, G.E., Parveen, Z., Wagner, C., et al. (2016) A Novel Microfluidic Platform for Size and Deformability Based Separation and the Subsequent Molecular Characterization of Viable Circulat-ing Tumor Cells. International Journal of Cancer, 138, 2894-2904. https://doi.org/10.1002/ijc.30007 |
| [29] | Descamps, L., Le Roy, D. and Deman, A.L. (2022) Microfluidic-Based Technologies for CTC Isolation: A Review of 10 Years of Intense Efforts towards Liquid Biopsy. International Journal of Molecular Sciences, 23, 1981.
https://doi.org/10.3390/ijms23041981 |
| [30] | Namli, I., Seyedmirzaei, S.S., Sheibani, A.A., et al. (2022) Hydrody-namic Cavitation on a Chip: A Tool to Detect Circulating Tumor Cells. ACS Applied Materials & Interfaces, 14, 40688-40697. https://doi.org/10.1021/acsami.2c12356 |
| [31] | Karthick, S., Pradeep, P.N., Kanchana, P., et al. (2018) Acoustic Impedance-Based Size-Independent Isolation of Circulating Tumour Cells from Blood Using Acoustophoresis. Lab on a Chip, 18, 3802-3813.
https://doi.org/10.1039/C8LC00921J |
| [32] | Magnusson, C., Augustsson, P., Lenshof, A., et al. (2017) Clini-cal-Scale Cell-Surface-Marker Independent Acoustic Microfluidic Enrichment of Tumor Cells from Blood. Analytical Chemistry, 89, 11954-11961.
https://doi.org/10.1021/acs.analchem.7b01458 |
| [33] | Nakashima, S., Natsugoe, S., Matsumoto, M., et al. (2003) Clinical Significance of Circulating Tumor Cells in Blood by Molecular Detection and Tumor Markers in Esophageal Cancer. Surgery, 133, 162-169.
https://doi.org/10.1067/msy.2003.9 |
| [34] | Matsutani, N., Sawabata, N., Yamaguchi, M., et al. (2017) Does Lung Cancer Surgery Cause Circulating Tumor Cells?—A Multicenter, Prospective Study. Journal of Thoracic Disease, 9, 2419-2426.
https://doi.org/10.21037/jtd.2017.07.33 |
| [35] | Guller, U., Zajac, P., Schnider, A., et al. (2002) Disseminated Single Tumor Cells as Detected by Real-Time Quantitative Polymerase Chain Reaction Represent a Prognostic Factor in Patients Undergoing Surgery for Colorectal Cancer. Annals of Surgery, 236, 768-776. https://doi.org/10.1097/00000658-200212000-00009 |
| [36] | Ikeguchi, M. and Kaibara, N. (2005) Detection of Circu-lating Cancer Cells after a Gastrectomy for Gastric Cancer. Surgery Today, 35, 436-441. https://doi.org/10.1007/s00595-004-2978-z |
| [37] | Yu, J., Xiao, W., Dong, S., et al. (2018) Effect of Surgical Liver Resection on Circulating Tumor Cells in Patients with Hepatocellular Carcinoma. BMC Cancer, 18, 835. https://doi.org/10.1186/s12885-018-4744-4 |
| [38] | Peach, G., Kim, C., Zacharakis, E., et al. (2010) Prognostic Sig-nificance of Circulating Tumour Cells Following Surgical Resection of Colorectal Cancers: A Systematic Review. British Journal of Cancer, 102, 1327-1334.
https://doi.org/10.1038/sj.bjc.6605651 |
| [39] | Kauffman, E.C., Lee, M.J., Alarcon, S.V., et al. (2016) Lack of Impact of Robotic Assisted Laparoscopic Radical Prostatectomy on Intraoperative Levels of Prostate Cancer Circulating Tumor Cells. Journal of Urology, 195, 1136-1142.
https://doi.org/10.1016/j.juro.2015.11.013 |
| [40] | Yin, X.D., Yuan, X., Xue, J.J., et al. (2012) Clinical Significance of Carcinoembryonic Antigen-, Cytokeratin 19-, or Survivin-Positive Circulating Tumor Cells in the Peripheral Blood of Esophageal Squamous Cell Carcinoma Patients Treated with Radiotherapy: Circulating Tumor Cells in ESCC. Diseases of the Esophagus, 25, 750-756.
https://doi.org/10.1111/j.1442-2050.2012.01326.x |
| [41] | Ye, Q., Ling, S., Zheng, S., et al. (2019) Liquid Biopsy in Hepatocellular Carcinoma: Circulating Tumor Cells and Circulating Tumor DNA. Molecular Cancer, 18, 114. https://doi.org/10.1186/s12943-019-1043-x |
| [42] | Jia, R., Zhao, C.H., Li, P.S., et al. (2020) Post-Radiation Circu-lating Tumor DNA as a Prognostic Factor in Locally Advanced Esophageal Squamous Cell Carcinoma. Oncology Let-ters, 21, 68. https://doi.org/10.3892/ol.2020.12329 |
| [43] | Allum, W.H., Stenning, S.P., Bancewicz, J., et al. (2009) Long-Term Results of a Randomized Trial of Surgery with or without Preoperative Chemotherapy in Esophageal Cancer. Journal of Clinical Oncology, 27, 5062-5067.
https://doi.org/10.1200/JCO.2009.22.2083 |
| [44] | Van Hagen, P., Hulshof, M.C., Van Lanschot, J.J.B., et al. (2012) Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer. New England Journal of Medicine, 366, 2074-2084. https://doi.org/10.1056/NEJMoa1112088 |
| [45] | Ando, N., Iizuka, T., Ide, H., et al. (2003) Surgery plus Chemotherapy Compared with Surgery Alone for Localized Squamous Cell Carcinoma of the Thoracic Esophagus: A Japan Clinical Oncology Group Study—JCOG9204. Journal of Clinical Oncology, 21, 4592-4596. https://doi.org/10.1200/JCO.2003.12.095 |
| [46] | Ando, N., Kato, H., Igaki, H., et al. (2012) A Randomized Trial Comparing Postoperative Adjuvant Chemotherapy with Cisplatin and 5-Fluorouracil Versus Preoperative Chemotherapy for Localized Advanced Squamous Cell Carcinoma of the Thoracic Esophagus (JCOG9907). Annals of Surgical Oncol-ogy, 19, 68-74.
https://doi.org/10.1245/s10434-011-2049-9 |
| [47] | Zhao, Y., Han, L., Zhang, W., et al. (2020) Preoperative Chemo-therapy Compared with Postoperative Adjuvant Chemotherapy for Squamous Cell Carcinoma of the Thoracic Oesopha-gus with the Detection of Circulating Tumour Cells Randomized Controlled Trial. International Journal of Surgery, 73, 1-8. https://doi.org/10.1016/j.ijsu.2019.11.005 |
| [48] | Han, L., Li, Y.J., Zhang, W.D., et al. (2019) Clinical Signifi-cance of Tumor Cells in the Peripheral Blood of Patients with Esophageal Squamous Cell Carcinoma. Medicine, 98, e13921. https://doi.org/10.1097/MD.0000000000013921 |
| [49] | Reeh, M., Effenberger, K.E., Koenig, A.M., et al. (2015) Circulating Tumor Cells as a Biomarker for Preoperative Prognostic Staging in Patients with Esophageal Cancer. Annals of Surgery, 261, 1124-1130.
https://doi.org/10.1097/SLA.0000000000001130 |
| [50] | Ren, Z., Hou, X., Xue, Z., et al. (2021) The Relationship between the Number of Circulating Tumor Cells and the Prognosis in Patients with Esophageal Squamous Cell Carcino-ma. Journal of Gastrointestinal Oncology, 12, 1265-1276.
https://doi.org/10.21037/jgo-21-409 |
| [51] | Konczalla, L., Ghadban, T., Effenberger, K.E., et al. (2021) Prospective Comparison of the Prognostic Relevance of Circulating Tumor Cells in Blood and Disseminated Tumor Cells in Bone Marrow of a Single Patient’s Cohort with Esophageal Cancer. Annals of Surgery, 273, 299-305. https://doi.org/10.1097/SLA.0000000000003406 |
| [52] | Court, C.M., Ankeny, J.S., Sho, S., et al. (2016) Circulating Tumor Cells in Gastrointestinal Cancer: Current Practices and Future Directions. In: Bentrem, D. and Benson, A.B., Eds., Gastrointestinal Malignancies, Springer International Publishing, Cham, 345-376. http://link.springer.com/10.1007/978-3-319-34244-3_17
https://doi.org/10.1007/978-3-319-34244-3_17 |
